Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5074089013 | Acetaminophen 325 mg and chlorzoxazone 500 mg and diclofenac sodium 50 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5074090016 | Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5074091017 | Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only chlorzoxazone and diclofenac and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Chlorzoxazone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Chlorzoxazone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Diclofenac sodium | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Diclofenac sodium | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR